About the Journal
1. About Us
Frontiers in Bioscience-Elite (Elite) is comprised of research in basic and clinical science. Starting from 2021, our international board of research-active academic Editors, led by Editor-in-Chief Baohong Zhang, is comprised of leaders in their respective fields.
Elite is a modern forum of scientific communication for global researchers, without regard to gender, ethnicity, sexual orientation, age, religion, or socio-economic status. Data and information useful to investigators in any discipline in biology and medicine including biochemistry, molecular biology, botany, agronomy, microbiology, parasitology, virology, immunology, biotechnology, marine biology, clinical and basic medicine, biomedical engineering, genetics, epidemiology and preventive medicine, ecology, entomology, bioinformatics will be published following peer-review. Considered manuscripts will include reviews and research articles in basic science and clinical science, as well as technical notes and protocols.
2. Copyright / Open Access
Starting from 2021, all content of Elite is available online, and is fully viewable and searchable. All manuscripts of Elite are published as open access articles under the unrestricted CC-BY license. The copyright is retained by the author(s).
BRI will insert the following note in the footer of the first page of the published text:
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
© 2021 The Authors. Published by BRI.
BRI has obtained the copyright of Elite's articles from Frontiers in Bioscience, Inc. which have been published from 1996 to January 2021.
3. Publication Ethics Statement
In line with our commitment to ethical publishing, we are dedicated to maintaining standards in areas such as publishing ethics, open access, and digital preservation of content.
Elite follows the best practices such as those outlined by these organizations:
4. Journal Metrics
Publication Frequency: 2 issues per year
Scopus CiteScore: 4.9